Funda Atalay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Funda Atalay has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Sakine Yılmaz
Çankırı Karatekin Üniversitesi
2 shared publications - Uğurcan Zorlu
Department of Perinatology, Ankara Bilkent City Hospital, Ankara, Turkey
2 shared publications - Yadigar Ordu
Necmettin Erbakan Üniversitesi, Hemşirelik Fakültesi
2 shared publications Ayse Filiz Avsar
1 shared publication- Cagatay Taskiran
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Koc University School of Medicine
1 shared publication - Cemal Reşat Atalay
Department of Obstetrics and Gynecology, University of Health Sciences, Ministry of Health Ankara City Hospital, Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
- 21 August 2026
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 46 (1)
Inflammatory markers and the systemic immune-inflammation index in endometrial carcinoma and hyperplasia: a retrospective cohort study
The link between chronic inflammation and cancer was first proposed by Virchow in the nineteenth century, and inflammation is now recognised as both a contributor to carcinogenesis and a consequenc...
- 21 August 2026
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 46 (1)
Open AccessInflammatory markers and the systemic immune-inflammation index in endometrial carcinoma and hyperplasia: a retrospective cohort study
The link between chronic inflammation and cancer was first proposed by Virchow in the nineteenth century, and inflammation is now recognised as both a contributor to carcinogenesis and a consequenc...
- Open Access
- 6 October 2025
- Published by Springer Nature in Journal of Religion and Health
- Vol. 65 (1) , 1128
Correction: Determination of Comfort Levels and Spiritual Care Needs of Gynecologic Cancer Patients with Abdominal Drains: a Cross-Sectional Descriptive Study in Turkey
- 6 October 2025
- Published by Springer Nature in Journal of Religion and Health
- Vol. 65 (1) , 1128
Open AccessCorrection: Determination of Comfort Levels and Spiritual Care Needs of Gynecologic Cancer Patients with Abdominal Drains: a Cross-Sectional Descriptive Study in Turkey
- Open Access
- 15 August 2025
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 55 (4) , 855-859
Evaluation of metabolic uptake in gynecological organs using FDG-PET in women diagnosed with non-gynecological malignancies
Background/aim: Gynecological malignancies, including those affecting the uterus, cervix, vagina, vulva, and adnexa, pose significant physical and psychosocial burdens. Early detection and effective management of these malignancies are critical for improving outcomes. This study aims to evaluate metabolic uptake patterns in gynecological organs using fluorodeoxyglucose positron emission tomography (FDG-PET) and to analyze their malignancy potential in women with nongynecological cancers. Materials and methods: A retrospective analysis was conducted on 221 women with nongynecological malignancies who exhibited pathological FDG uptake in gynecological organs on FDG-PET/CT imaging. Lesions were evaluated based on the standardized uptake value maximum (SUVmax), morphological characteristics on contrast-enhanced CT, and further gynecological assessment using ultrasonography, biopsy, and endometrial sampling. Statistical analyses, including the receiver operating characteristics curve and descriptive statistics, were performed using SPSS software, with significance set at p < 0.05. Results: Pathological FDG uptake was observed in the uterus (60.6%), adnexa (30.3%), cervix (14.02%), vulva (4%), and vagina (2.2%). The mean SUVmax of lesions varied across sites, with uterine lesions showing a mean SUVmax of 6.96 ± 3.55. An SUVmax cutoff of >10.11 predicted malignancy in uterine lesions with 86% sensitivity and 82% specificity. Among patients with uterine involvement, malignancy was confirmed in 10 cases, all of whom were on tamoxifen therapy. Endometrial thickness was significantly higher in malignancy cases (10.6 mm vs. 5.8 mm, p = 0.014). Ultrasonography and biopsy findings largely confirmed the benign nature of other lesions, highlighting the role of multimodal diagnostic approaches. Conclusion: FDG-PET imaging is a valuable tool for identifying metabolic activity in gynecological organs and for differentiating malignant lesions from benign ones. High SUVmax values and endometrial thickness are significant indicators of malignancy, particularly in patients undergoing hormonal therapy. This study underscores the importance of integrating metabolic imaging with clinical and morphological assessments for the early detection and management of gynecological malignancies.
- 15 August 2025
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 55 (4) , 855-859
Open AccessEvaluation of metabolic uptake in gynecological organs using FDG-PET in women diagnosed with non-gynecological malignancies
Background/aim: Gynecological malignancies, including those affecting the uterus, cervix, vagina, vulva, and adnexa, pose significant physical and psychosocial burdens. Early detection and effective management of these malignancies are critical for improving outcomes. This study aims to evaluate metabolic uptake patterns in gynecological organs using fluorodeoxyglucose positron emission tomography (FDG-PET) and to analyze their malignancy potential in women with nongynecological cancers. Materials and methods: A retrospective analysis was conducted on 221 women with nongynecological malignancies who exhibited pathological FDG uptake in gynecological organs on FDG-PET/CT imaging. Lesions were evaluated based on the standardized uptake value maximum (SUVmax), morphological characteristics on contrast-enhanced CT, and further gynecological assessment using ultrasonography, biopsy, and endometrial sampling. Statistical analyses, including the receiver operating characteristics curve and descriptive statistics, were performed using SPSS software, with significance set at p < 0.05. Results: Pathological FDG uptake was observed in the uterus (60.6%), adnexa (30.3%), cervix (14.02%), vulva (4%), and vagina (2.2%). The mean SUVmax of lesions varied across sites, with uterine lesions showing a mean SUVmax of 6.96 ± 3.55. An SUVmax cutoff of >10.11 predicted malignancy in uterine lesions with 86% sensitivity and 82% specificity. Among patients with uterine involvement, malignancy was confirmed in 10 cases, all of whom were on tamoxifen therapy. Endometrial thickness was significantly higher in malignancy cases (10.6 mm vs. 5.8 mm, p = 0.014). Ultrasonography and biopsy findings largely confirmed the benign nature of other lesions, highlighting the role of multimodal diagnostic approaches. Conclusion: FDG-PET imaging is a valuable tool for identifying metabolic activity in gynecological organs and for differentiating malignant lesions from benign ones. High SUVmax values and endometrial thickness are significant indicators of malignancy, particularly in patients undergoing hormonal therapy. This study underscores the importance of integrating metabolic imaging with clinical and morphological assessments for the early detection and management of gynecological malignancies.
- 30 September 2024
- Published by Springer Nature in Journal of Religion and Health
- Vol. 64 (1) , 519-535
Determination of Comfort Levels and Spiritual Care Needs of Gynecologic Cancer Patients with Abdominal Drains: A Cross-Sectional Descriptive Study in Turkey
This study was conducted to determine the comfort levels and spiritual care needs of gynecologic cancer patients with abdominal drains. The study was conducted with 61 gynecologic cancer patients with abdominal drains at the gynecologic oncology surgery clinic of a state hospital in Turkey. Data were collected using the “Participant Information Form,” “Perianesthesia Comfort Questionnaire (PCQ)”, and “Spiritual Care Needs Inventory”. Kolmogorov-Smirnov test and Mann-Whitney U test were used to analyze the data. It was found that the postoperative comfort of the patients in this study was above a moderate level. Patients who did not need spiritual care, did not fulfil religious rituals regularly and did not receive social support had a high level of comfort in the early postoperative period. Patients with gynecologic cancer were found to have high spiritual care needs. Patients without chronic diseases, possessing a single abdominal drain, familiar with the concept of spiritual care, expressing a need for spiritual care, engaging in regular religious rituals, and enjoying social support were identified as having elevated spiritual care needs. Within the framework of holistic nursing care provided to gynecologic cancer patients with abdominal drains, the results reveal the necessity of spiritual care and the importance of comfort.
- 30 September 2024
- Published by Springer Nature in Journal of Religion and Health
- Vol. 64 (1) , 519-535
Determination of Comfort Levels and Spiritual Care Needs of Gynecologic Cancer Patients with Abdominal Drains: A Cross-Sectional Descriptive Study in Turkey
This study was conducted to determine the comfort levels and spiritual care needs of gynecologic cancer patients with abdominal drains. The study was conducted with 61 gynecologic cancer patients with abdominal drains at the gynecologic oncology surgery clinic of a state hospital in Turkey. Data were collected using the “Participant Information Form,” “Perianesthesia Comfort Questionnaire (PCQ)”, and “Spiritual Care Needs Inventory”. Kolmogorov-Smirnov test and Mann-Whitney U test were used to analyze the data. It was found that the postoperative comfort of the patients in this study was above a moderate level. Patients who did not need spiritual care, did not fulfil religious rituals regularly and did not receive social support had a high level of comfort in the early postoperative period. Patients with gynecologic cancer were found to have high spiritual care needs. Patients without chronic diseases, possessing a single abdominal drain, familiar with the concept of spiritual care, expressing a need for spiritual care, engaging in regular religious rituals, and enjoying social support were identified as having elevated spiritual care needs. Within the framework of holistic nursing care provided to gynecologic cancer patients with abdominal drains, the results reveal the necessity of spiritual care and the importance of comfort.
- 17 April 2023
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Analysis of the Gynecologic Cancer Surgery with Pre-pandemic Protocols in a COVID-19 Free Cancer Center Gynecologic Cancer Surgery in COVID-19 Free Center
Objective: COVID-19 has caused a rapid transformation in the healthcare system, including in particular, the care of vulnerable cancer patients. The aim of this study was to present our clinical experience in gynecological cancer surgeries in a COVID-19-free cancer hospital during the pandemic. Methods: A retrospective analysis was made of the data of patients with ovarian, endometrium, cervix and vulva cancers who were treated with surgery between March 2020 and March 2021, with particular focus on the complication rates on day 30, and at the end of one year. Results: The study included a total of 74 patients with mean age of 59 years. The most common diagnosis was ovarian cancer (48.6%) followed by endometrial (43.2%), cervical (6.8%) and vulvar cancer (1.4%). Most of the patients were in advanced stage (FIGO 3 and 4) of ovarian (86%), endometrial (59.4%) and cervical local advanced (60%) cancer. The complication rate was 17.6 %. Surgery was delayed in one patient with a preoperative positive polymerase chain reaction (PCR) test for COVID-19 infection, and none of the patients had a positive test result in the early postoperative period. Conclusion: COVID-19-free institutions for cancer surgery, is an effective treatment strategy in the context of the pandemic. The results of this study indicate that continuity of cancer treatment can be achieved safely, with strict adherence to COVID-19 precautions for both patients and healthcare workers. Keywords: COVID-19, gynecological cancer, surgery, treatment
- 17 April 2023
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Analysis of the Gynecologic Cancer Surgery with Pre-pandemic Protocols in a COVID-19 Free Cancer Center Gynecologic Cancer Surgery in COVID-19 Free Center
Objective: COVID-19 has caused a rapid transformation in the healthcare system, including in particular, the care of vulnerable cancer patients. The aim of this study was to present our clinical experience in gynecological cancer surgeries in a COVID-19-free cancer hospital during the pandemic. Methods: A retrospective analysis was made of the data of patients with ovarian, endometrium, cervix and vulva cancers who were treated with surgery between March 2020 and March 2021, with particular focus on the complication rates on day 30, and at the end of one year. Results: The study included a total of 74 patients with mean age of 59 years. The most common diagnosis was ovarian cancer (48.6%) followed by endometrial (43.2%), cervical (6.8%) and vulvar cancer (1.4%). Most of the patients were in advanced stage (FIGO 3 and 4) of ovarian (86%), endometrial (59.4%) and cervical local advanced (60%) cancer. The complication rate was 17.6 %. Surgery was delayed in one patient with a preoperative positive polymerase chain reaction (PCR) test for COVID-19 infection, and none of the patients had a positive test result in the early postoperative period. Conclusion: COVID-19-free institutions for cancer surgery, is an effective treatment strategy in the context of the pandemic. The results of this study indicate that continuity of cancer treatment can be achieved safely, with strict adherence to COVID-19 precautions for both patients and healthcare workers. Keywords: COVID-19, gynecological cancer, surgery, treatment
- Open Access
- 19 December 2018
- Published by Heighten Science Publications Corporation in Clinical Journal of Obstetrics and Gynecology
- Vol. 1 (2) , 073-081
The predictive value of the preoperative diagnostic tests in mature cystic teratomas of the ovary
Aim: The aim of this study was to determine the sensitivity of the tumor markers and diagnostic methods used in the preoperative period for dermoid cysts, the most common benign neoplasm of the ovary. Material and Methods: 136 patients who were operated for any reason and reported as ovarian dermoid cyst in the Department of Obstetrics and Gynecology, Ankara Atatürk Training and Research Hospital between January 2004 and September 2005 were included in the study. The medical records of the cases were obtained retrospectively from Ankara-Atatürk Training and Research Hospital, HIS, archive files and patient numbers where necessary. Results: In the preoperative period, 119 patients underwent ultrasonographic examination, 33 underwent Computed Tomography, and 17 underwent Magnetic Resonance Imaging.10 of the cases only underwent CT, while 3 of the cases underwent only MRI 22 of them underwent both USG and CT, USG and MRI were performed on 13 cases and only 1 case underwent all three of the imaging methods. Tumor markers were CEA, CA 125, CA 19-9, CA 15-3 and AFP. Conclusions: The reviews of ultrasonography and / or computed tomography and / or magnetic resonance imaging (n = 132) revealed that 103 of the cases were put into operation and the sensitivity of the preoperative screening methods were calculated to be 75.5%. The sensitivity of the tumor marker CA 19-9 was calculated to be 31%.
- 19 December 2018
- Published by Heighten Science Publications Corporation in Clinical Journal of Obstetrics and Gynecology
- Vol. 1 (2) , 073-081
Open AccessThe predictive value of the preoperative diagnostic tests in mature cystic teratomas of the ovary
Aim: The aim of this study was to determine the sensitivity of the tumor markers and diagnostic methods used in the preoperative period for dermoid cysts, the most common benign neoplasm of the ovary. Material and Methods: 136 patients who were operated for any reason and reported as ovarian dermoid cyst in the Department of Obstetrics and Gynecology, Ankara Atatürk Training and Research Hospital between January 2004 and September 2005 were included in the study. The medical records of the cases were obtained retrospectively from Ankara-Atatürk Training and Research Hospital, HIS, archive files and patient numbers where necessary. Results: In the preoperative period, 119 patients underwent ultrasonographic examination, 33 underwent Computed Tomography, and 17 underwent Magnetic Resonance Imaging.10 of the cases only underwent CT, while 3 of the cases underwent only MRI 22 of them underwent both USG and CT, USG and MRI were performed on 13 cases and only 1 case underwent all three of the imaging methods. Tumor markers were CEA, CA 125, CA 19-9, CA 15-3 and AFP. Conclusions: The reviews of ultrasonography and / or computed tomography and / or magnetic resonance imaging (n = 132) revealed that 103 of the cases were put into operation and the sensitivity of the preoperative screening methods were calculated to be 75.5%. The sensitivity of the tumor marker CA 19-9 was calculated to be 31%.
- Open Access
- 6 August 2018
- Published by Juniper Publishers in Journal of Gynecology and Womens Health
- Vol. 11 (1) , 1-3
A Rare Ovarian Tumor: Granulocytic Sarcoma-Case Report
Granulocytic sarcoma is a hematological malignancy of myeloblasts or immature myeloid cells that hold an extramedullary anatomical region. This neoplasm is in the literature; myeloid sarcoma, extramedullary myeloid cell tumor, myeloblastoma, chloroma. These tumors rarely occur in any anatomical region without known hematolymphoid disease. Granulocytic sarcoma in the gynecologic tract is very rare.
- 6 August 2018
- Published by Juniper Publishers in Journal of Gynecology and Womens Health
- Vol. 11 (1) , 1-3
Open AccessA Rare Ovarian Tumor: Granulocytic Sarcoma-Case Report
Granulocytic sarcoma is a hematological malignancy of myeloblasts or immature myeloid cells that hold an extramedullary anatomical region. This neoplasm is in the literature; myeloid sarcoma, extramedullary myeloid cell tumor, myeloblastoma, chloroma. These tumors rarely occur in any anatomical region without known hematolymphoid disease. Granulocytic sarcoma in the gynecologic tract is very rare.
- 12 November 2007
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 33 (6) , 823-828
Detection of human papillomavirus DNA and genotyping in patients with epithelial ovarian carcinoma
Aim: The purpose of this study was to investigate the possible role of human papillomavirus (HPV) in Turkish patients with epithelial ovarian cancer by using the highly sensitive technique of polymerase chain reaction (PCR) to identify all the subtypes of this unique oncogenic virus.Methods: All patients were subjected to initial surgery, and subsequently recruited for postoperative chemotherapy depending on the extent of the disease and their condition. HPV PCR screening was done from paraffin embedded samples. PCR amplifications were done using the MY09/11 primer set after digestion and phenol–chloroform extraction of the DNA. HPV PCR‐positive samples were analyzed and genotyped using an OpenGene automated DNA sequencing system.Results: Overall, 94 patients were included in this study. The mean age was 52.7 years (range, 21–76 years). As a histopathologic diagnosis, the majority of the patients had serous papillary tumors (81%). HPV was found to be positive in eight patients (8.5%). All of the positive patients had serous papillary tumors (8/76, 10.5%) and advanced stage disease. Six patients had HPV type 16, and the remaining two patients had HPV type 33. None of the patients had more than one type of HPV.Conclusion: HPV may have a role in the carcinogenesis of ovarian cancer. It is worth investigating this possible relation both in large case–control studies and in vitro models by using more sensitive techniques.
- 12 November 2007
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 33 (6) , 823-828
Detection of human papillomavirus DNA and genotyping in patients with epithelial ovarian carcinoma
Aim: The purpose of this study was to investigate the possible role of human papillomavirus (HPV) in Turkish patients with epithelial ovarian cancer by using the highly sensitive technique of polymerase chain reaction (PCR) to identify all the subtypes of this unique oncogenic virus.Methods: All patients were subjected to initial surgery, and subsequently recruited for postoperative chemotherapy depending on the extent of the disease and their condition. HPV PCR screening was done from paraffin embedded samples. PCR amplifications were done using the MY09/11 primer set after digestion and phenol–chloroform extraction of the DNA. HPV PCR‐positive samples were analyzed and genotyped using an OpenGene automated DNA sequencing system.Results: Overall, 94 patients were included in this study. The mean age was 52.7 years (range, 21–76 years). As a histopathologic diagnosis, the majority of the patients had serous papillary tumors (81%). HPV was found to be positive in eight patients (8.5%). All of the positive patients had serous papillary tumors (8/76, 10.5%) and advanced stage disease. Six patients had HPV type 16, and the remaining two patients had HPV type 33. None of the patients had more than one type of HPV.Conclusion: HPV may have a role in the carcinogenesis of ovarian cancer. It is worth investigating this possible relation both in large case–control studies and in vitro models by using more sensitive techniques.